AXOGEN, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.2 USD | +2.65% |
|
+7.77% | -8.64% |
| May. 16 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
| May. 02 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 6.970 | 8.070 | 10.69 |
| Spread/Res. | -10.47% | -22.68% | -41.63% |
| Spread/Supp. | +10.05% | +10.05% | +67.29% |
| Support | 5.670 | 5.670 | 3.730 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AXGN Stock
- Charts AxoGen, Inc.
